Not recruiting yet
Minimally Invasive Surgery for Spontaneous Deep Intracerebral Hemorrhage
NCT07710313 · Tam Anh Research Institute · Updated 30 Sept 2026
- What is being tested
- Minimally Invasive Surgery (MIS); Standard medical treatment (SMT)
- For
- Intracerebral Hemorrhage; Spontaneous Intracerebral Hemorrhage; Basal Ganglia Hemorrhage
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 300 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started 1 Nov 2026, ends 31 Dec 2028. Registered 17 July 2026.
- Results
- None posted yet.
In the researchers' words
This observational cohort study evaluates the real-world effectiveness and safety of minimally invasive surgery (MIS) versus standard medical management in adults with spontaneous deep intracerebral hemorrhage. Patients presenting to Tam Anh General Hospital and People's Hospital 115 within 72 hours of hemorrhage onset will be enrolled and followed for 180 days. Clinical, radiological, and treatment-related variables will be collected, with primary outcome measures including survival and functional outcomes during follow-up period.
